申请人:Zhang Jie
公开号:US20120015952A1
公开(公告)日:2012-01-19
The invention relates to compounds of formulae (1) and (2):
and pharmaceutically acceptable salts thereof for the treatment of cancer, inflammation, auto-immune diseases, diabetes and diabetic complications, infection, cardiovascular disease and ischemia-reperfusion injuries.
该发明涉及式(1)和式(2)的化合物及其药学上可接受的盐,用于治疗癌症,炎症,自身免疫性疾病,糖尿病和糖尿病并发症,感染,心血管疾病和缺血再灌注损伤。